692
Total Claims
$792K
Drug Cost
177
Beneficiaries
$4,472
Cost/Patient
Peer Comparison vs. 775 Hematology providers
-75%
Cost per patient vs peers
$4,472 vs $18K avg
-42%
Brand preference vs peers
13.4% vs 23.1% avg
Brand vs Generic
87% generic
Brand: 93 claims · $681K
Generic: 599 claims · $111K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Enzalutamide | 11 | $171K |
| Apixaban | 43 | $48K |
| Abiraterone Acetate | 13 | $27K |
| Anastrozole | 82 | $2,483 |
| Prochlorperazine Maleate | 92 | $1,097 |
| Ondansetron | 82 | $942 |
| Lidocaine/Prilocaine | 54 | $880 |
| Tamoxifen Citrate | 27 | $754 |
| Dexamethasone | 33 | $715 |
| Letrozole | 23 | $358 |
| Acyclovir | 26 | $316 |
| Levofloxacin | 11 | $232 |
| Prednisone | 31 | $126 |
| Folic Acid | 11 | $20 |
Prescribing Profile
14
Unique Drugs
Patient Profile
73
Avg Age
64%
Female
1.57
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About